Publications by authors named "Rainer Boer"

Claim this Profile
N
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.
Ulrich Grädler, Thomas Fuchss, Wolf-Rüdiger Ulrich, Rainer Boer, Andreas Strub

Bioorg Med Chem Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of inducible nitric oxide synthase in respiratory diseases.
Christian Hesslinger, Andreas Strub, Rainer Boer, Wolf-Rüdiger Ulrich, Martin D Lehner

Biochem Soc Trans· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Tobias Eltze, Rainer Boer, Thomas Wagner, Steffen Weinbrenner, Michelle C McDonald

Mol Pharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Mauro Tiso, Andreas Strub, Christian Hesslinger, Claire T Kenney, Rainer Boer

Mol Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase.
Martin D Lehner, Degenhard Marx, Rainer Boer, Andreas Strub, Christian Hesslinger

J Pharmacol Exp Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.
Soni Savai Pullamsetti, Daniel Maring, Hossein Ardeschir Ghofrani, Konstantin Mayer, Norbert Weissmann, Rainer Boer

Thromb Haemost· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Andreas Strub, Wolf-Rüdiger Ulrich, Christian Hesslinger, Manfrid Eltze, Thomas Fuchss, Rainer Boer

Mol Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
Christoph Borchers, Rainer Boer, Kurt Klemm, Volker Figala, Thomas Denzinger

Mol Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis